Ameriprise’s Dicerna Pharmaceuticals DRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DRNA
ACM
Ameriprise's DRNA Position: Q2 2021 in Review
Ameriprise sold out of Dicerna Pharmaceuticals (DRNA) in Q2 2021, closing a stake of 22,063 shares — an estimated $564K sold.
Ameriprise first reported a position in DRNA in Q1 2014 and held it in 6 quarters. The position peaked at $2.45M in Q1 2014. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.
- Ameriprise reported no remaining Dicerna Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Ameriprise sold 22,063 Dicerna Pharmaceuticals shares in Q2 2021, an estimated $564K.
- Ameriprise first reported a position in Dicerna Pharmaceuticals in Q1 2014 and held it in 6 quarters.
- Ameriprise's Dicerna Pharmaceuticals position peaked at $2.45M in Q1 2014.
- 203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals as of Q2 2021.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.